Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
BIDU-SW
09888
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 5.43%95.49B | 8.02%90.57B | 10.87%23.6B | 10.14%23.75B | 4.02%22.09B | 6.96%21.13B | 2.89%83.84B | -0.06%21.29B | 0.26%21.57B | 10.62%21.24B |
| Cost of revenue | 4.87%79.92B | 7.02%76.21B | 4.84%19.19B | 7.37%19.48B | 5.79%19.01B | 10.35%18.54B | 2.90%71.21B | 4.70%18.3B | 1.53%18.14B | 6.80%17.97B |
| Gross profit | 8.42%15.57B | 13.66%14.36B | 47.81%4.41B | 24.84%4.27B | -5.72%3.08B | -12.32%2.59B | 2.82%12.63B | -21.80%2.99B | -6.07%3.42B | 37.78%3.27B |
| Operating expense | 8.59%11.76B | 8.01%10.83B | 19.64%3.01B | 7.26%2.72B | -2.06%2.57B | 7.60%2.53B | 8.22%10.03B | 1.37%2.52B | 7.42%2.53B | 19.54%2.62B |
| Staff costs | ---- | ---- | ---- | ---- | ---- | 11.24%1.05B | ---- | ---- | 5.09%991M | 7.40%972M |
| Other operating expenses | ---- | ---- | ---- | ---- | ---- | 5.17%1.49B | ---- | ---- | 8.98%1.54B | 28.06%1.65B |
| Operating profit | 7.91%3.81B | 35.42%3.53B | 198.51%1.4B | 74.92%1.56B | -20.56%514M | -90.50%57M | -13.74%2.61B | -64.82%470M | -30.82%889M | 261.45%647M |
| Net non-operating interest income (expenses) | -118.93%-451M | 21.37%-206M | -1.56%-65M | 30.77%-54M | 71.43%-18M | -21.05%-69M | -34.36%-262M | -25.49%-64M | -65.96%-78M | -31.25%-63M |
| Non-operating interest income | -15.50%109M | 514.29%129M | 130.00%23M | 500.00%36M | 1,450.00%62M | 700.00%8M | 133.33%21M | 233.33%10M | 200.00%6M | 100.00%4M |
| Non-operating interest expense | 67.16%560M | 18.37%335M | 18.92%88M | 7.14%90M | 19.40%80M | 32.76%77M | 38.73%283M | 37.04%74M | 71.43%84M | 34.00%67M |
| Net investment income | 56.10%2.08B | 201.35%1.34B | 118.49%66M | -48.21%174M | 30.05%476M | 531.63%619M | -39.81%443M | -163.98%-357M | -0.88%336M | 275.12%366M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 132.61%15M | -118.78%-46M | -98.59%4M | 76.32%-9M | 17M | -58M | 245M | 283M | -38M | 0 |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 65.40%-201M | -59.62%-581M | 24.49%-185M | -148.00%-62M | -346.30%-241M | -132.50%-93M | -313.64%-364M | 3.54%-245M | 0.00%-25M | -124.32%-54M |
| Less:Restructuring and mergern&acquisition | --0 | 101.87%216M | --0 | --0 | ---- | ---- | --107M | --107M | --0 | ---- |
| Less:Other special charges | -36.01%183M | 17.70%286M | -14.52%106M | 148.00%62M | -53.70%25M | 132.50%93M | 1,835.71%243M | -18.42%124M | 0.00%25M | 124.32%54M |
| Less:Write off | -77.22%18M | 464.29%79M | ---- | ---- | ---- | ---- | -86.27%14M | ---- | ---- | ---- |
| Other non-operating income (expenses) | -32.85%92M | 184.05%137M | -14M | 53M | 173.33%44M | 134.78%54M | -259.80%-163M | -215.79%-60M | ||
| Income before tax | 28.32%5.35B | 66.55%4.17B | 1,632.91%1.21B | 47.28%1.65B | -4.91%794M | -18.46%508M | -30.05%2.5B | -104.68%-79M | -29.42%1.12B | 573.39%835M |
| Income tax | 784.66%1.44B | -78.55%163M | -306.33%-652M | 143.88%339M | 23.91%171M | 82.63%305M | 53.54%760M | 953.33%316M | -45.28%139M | -0.72%138M |
| Net income | -2.50%3.9B | 129.79%4B | 571.39%1.86B | 33.60%1.32B | -10.76%622M | -55.38%203M | -43.46%1.74B | -123.81%-395M | -26.27%985M | 4,456.25%697M |
| Net income continuous operations | -2.47%3.91B | 129.85%4B | 571.65%1.86B | 33.64%1.32B | -10.62%623M | -55.48%203M | -43.48%1.74B | -123.82%-395M | -26.40%984M | 4,746.67%697M |
| Noncontrolling interests | -22.97%114M | -3.27%148M | -60.00%14M | 97.14%69M | 11.48%68M | -113.64%-3M | -48.31%153M | -81.18%35M | -5.41%35M | 64.86%61M |
| Net income attributable to the company | -1.71%3.79B | 142.76%3.86B | 530.00%1.85B | 31.26%1.25B | -13.05%553M | -52.31%206M | -42.98%1.59B | -129.17%-430M | -26.81%950M | 1,323.08%636M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -1.71%3.79B | 142.76%3.86B | 530.00%1.85B | 31.26%1.25B | -13.05%553M | -52.31%206M | -42.98%1.59B | -129.17%-430M | -26.81%950M | 1,323.08%636M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -17.16%53.19 | 139.32%64.21 | 517.06%30.32 | 31.21%21.06 | -13.12%9.34 | -52.19%3.49 | -42.98%26.83 | -129.21%-7.27 | -26.85%16.05 | 1,307.87%10.75 |
| Diluted earnings per share | -17.16%53.19 | 139.32%64.21 | 457.06%25.958 | 31.22%21.0533 | -13.08%9.3362 | -52.19%3.49 | -42.98%26.83 | -129.21%-7.27 | -26.83%16.0438 | 1,306.85%10.7409 |
| Dividend per share | 5.26%20 | 123.53%19 | 123.53%19 | 0 | 0 | 0 | -39.29%8.5 | -39.29%8.5 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |